Related Experiment Video

Updated: Jul 1, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.0K

How CBX proteins regulate normal and leukemic blood cells

Anne P de Groot1,2, Gerald de Haan1,2,3

  • 1European Research Institute for Biology of Ageing (ERIBA), University Medical Center Groningen (UMCG), The Netherlands.

FEBS Letters
|March 1, 2024
PubMed

Insights

Chromobox (CBX) proteins within Polycomb Repressive Complex 1 (PRC1) regulate hematopoietic stem cell (HSC) self-renewal. Different CBX proteins influence HSC fate, aging, and leukemia, offering therapeutic targets.

Area of Science:

  • Hematology
  • Epigenetics
  • Molecular Biology

Background:

  • Hematopoietic stem cell (HSC) self-renewal is crucial for blood formation and is regulated by epigenetic mechanisms.
  • Polycomb Repressive Complex 1 (PRC1) plays a key role in repressing differentiation genes, maintaining HSC function.
  • The specific chromobox (CBX) protein subunit of PRC1 influences HSC fate decisions.

Purpose of the Study:

  • To review the diverse roles of chromobox (CBX) proteins in regulating hematopoietic stem cell (HSC) fate.
  • To explore how CBX proteins contribute to age-related changes and oncogenic transformations in HSCs.
  • To discuss therapeutic strategies targeting CBX proteins in leukemia.

Main Methods:

  • Literature review of studies on PRC1, CBX proteins, and HSC biology.
  • Analysis of the epigenetic and non-epigenetic functions of CBX proteins.
  • Examination of the impact of CBX proteins on HSC self-renewal, aging, and leukemogenesis.

Main Results:

  • Different CBX proteins (CBX2, CBX4, CBX6, CBX7, CBX8) within PRC1 lead to distinct HSC fate outcomes.
  • CBX proteins influence age-related HSC alterations and promote oncogenic pathways.
  • CBX2, CBX7, and CBX8 are implicated in enhancing leukemia progression.
  • Both canonical epigenetic and alternative non-epigenetic interactions of CBX proteins are relevant.

Conclusions:

  • CBX proteins are critical regulators of HSC fate, with specific subunits impacting self-renewal, aging, and disease.
  • Targeting the epigenetic functions of oncogenic CBX proteins presents a promising therapeutic avenue for leukemia.
  • Further research is needed to elucidate the non-epigenetic roles of cytoplasmic CBX proteins in blood cell development and disease.

Keywords:
CBXHSCPRC1Polycombagingepigeneticshematopoiesisleukemiasubcellular CBX localization

More Related Videos

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.2K
Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

11.7K

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
950